Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.
Neuronal damage is the morphological substrate of persisting neurological disability. Neurofilaments (Nf) are cytoskeletal proteins of neurons and their release into cerebrospinal fluid has shown encouraging results as a biomarker for neurodegeneration. This study aimed to validate the quantificatio...
Main Authors: | Johanna Gaiottino, Niklas Norgren, Ruth Dobson, Joanne Topping, Ahuva Nissim, Andrea Malaspina, Jonathan P Bestwick, Andreas U Monsch, Axel Regeniter, Raija L Lindberg, Ludwig Kappos, David Leppert, Axel Petzold, Gavin Giovannoni, Jens Kuhle |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3779219?pdf=render |
Similar Items
-
Neurofilament light as a marker for neurodegenerative diseases
by: Norgren, Niklas
Published: (2004) -
Blood neurofilament light as a potential endpoint in Phase 2 studies in MS
by: Maria Pia Sormani, et al.
Published: (2019-06-01) -
The Diagnostic and Prognostic Value of Neurofilament Heavy Chain Levels in Immune-Mediated Optic Neuropathies
by: Axel Petzold, et al.
Published: (2012-01-01) -
Author Correction: The potential of neurofilaments analysis using dry-blood and plasma spots
by: Vittoria Lombardi, et al.
Published: (2020-06-01) -
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias
by: Samir Abu-Rumeileh, et al.
Published: (2018-01-01)